DreamCIS, Inc. (KOSDAQ:223250)
South Korea · Delayed Price · Currency is KRW 3,575.00
+100.00 (2.88%)
At close: Aug 11, 2026
DreamCIS Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 69,872 | 66,631 | 58,653 | 47,844 | 38,874 | 26,153 |
Revenue Growth | 14.75% | 13.60% | 22.59% | 23.08% | 48.64% | 11.34% |
Gross Profit Gross Profit Growth | 19,094 | 19,376 | 17,862 | 12,939 | 13,865 | 8,691 |
Operating Income Operating Income Growth | 4,450 | 5,238 | 4,462 | 1,588 | 5,818 | 3,617 |
Net Income Net Income Growth | 6,161 | 7,126 | 5,280 | 3,739 | 4,405 | 3,229 |
Earnings Per Share EPS Growth | 258.27 | 297.65 | 221.07 | 156.74 | 193.97 | 143.00 |
EPS Growth | 9.65% | 34.64% | 41.05% | -19.19% | 35.64% | -39.85% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Clinical Trial Human Resources Support Department Clinical Trial Human Resources Support Department Growth | 5,661 | 1,094 | - | - |
Consolidation Adjustment Consolidation Adjustment Growth | -3,804 | -2,776 | -1,721 | -576.65 |
Medical Consulting Medical Consulting Growth | 15,426 | 15,050 | 15,142 | 7,250 |
Clinical Trial Management Agency Clinical Trial Management Agency Growth | 49,348 | 45,285 | 34,424 | 32,200 |
Total Total Growth | 66,631 | 58,653 | 47,844 | 38,874 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 43,235 | 36,839 | 30,974 | 21,077 | 22,990 | 32,492 |
Total Debt Total Debt Growth | 16,442 | 16,758 | 3,768 | 4,291 | 5,431 | 3,509 |
Net Cash (Debt) Net Cash Growth | 26,792 | 20,081 | 27,206 | 16,786 | 17,559 | 28,983 |
Net Cash Growth | -19.78% | -26.19% | 62.08% | -4.40% | -39.42% | -6.04% |
Net Cash Per Share Net Cash Per Share Growth | 1129.26 | 842.67 | 1144.75 | 716.32 | 772.38 | 1284.26 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 11,999 | 14,065 | -85.19 | 7,333 | 9,083 | 5,882 |
Capital Expenditures CapEx Growth | -3,801 | -3,707 | -998.72 | -615.38 | -590.56 | -991.96 |
Free Cash Flow Free Cash Flow Growth | 8,198 | 10,358 | -1,084 | 6,718 | 8,492 | 4,890 |
Free Cash Flow Growth | -19.82% | - | - | -20.89% | 73.66% | 55.50% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 27.33% | 29.08% | 30.45% | 27.04% | 35.67% | 33.23% |
Operating Margin | 6.37% | 7.86% | 7.61% | 3.32% | 14.96% | 13.83% |
Pretax Margin | 13.15% | 16.36% | 10.54% | 9.21% | 13.26% | 15.09% |
Profit Margin | 8.82% | 10.70% | 9.00% | 7.81% | 11.33% | 12.35% |
FCF Margin | 11.73% | 15.54% | -1.85% | 14.04% | 21.85% | 18.70% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 12, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 13.84 | 21.31 | 13.30 | 20.64 | 14.00 | 22.70 |
Forward PE | 8.14 | 11.14 | 11.14 | 11.14 | 11.14 | 11.14 |
P/FCF Ratio | 10.73 | 14.66 | - | 11.49 | 7.26 | 14.99 |
PS Ratio | 1.26 | 2.28 | 1.20 | 1.61 | 1.59 | 2.80 |